Literature DB >> 26188694

Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy.

Lisa M Arendt1,2,3,4, Charlotte Kuperwasser5,6,7,8.   

Abstract

The mammary gland undergoes dramatic post-natal growth beginning at puberty, followed by full development occurring during pregnancy and lactation. Following lactation, the alveoli undergo apoptosis, and the mammary gland reverses back to resemble the nonparous gland. This process of growth and regression occurs for multiple pregnancies, suggesting the presence of a hierarchy of stem and progenitor cells that are able to regenerate specialized populations of mammary epithelial cells. Expansion of epithelial cell populations in the mammary gland is regulated by ovarian steroids, in particular estrogen acting through its receptor estrogen receptor alpha (ERα) and progesterone signaling through progesterone receptor (PR). A diverse number of stem and progenitor cells have been identified based on expression of cell surface markers and functional assays. Here we review the current understanding of how estrogen and progesterone act together and separately to regulate stem and progenitor cells within the human and mouse mammary tissues. Better understanding of the hierarchal organization of epithelial cell populations in the mammary gland and how the hormonal milieu affects its regulation may provide important insights into the origins of different subtypes of breast cancer.

Entities:  

Keywords:  Breast; Estrogen; Mammary epithelial cells; Progenitor cells; Progesterone

Mesh:

Substances:

Year:  2015        PMID: 26188694      PMCID: PMC4596764          DOI: 10.1007/s10911-015-9337-0

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  171 in total

1.  The shape of age-incidence curves of female breast cancer by hormone-receptor status.

Authors:  Y Yasui; J D Potter
Journal:  Cancer Causes Control       Date:  1999-10       Impact factor: 2.506

2.  C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development.

Authors:  T N Seagroves; J P Lydon; R C Hovey; B K Vonderhaar; J M Rosen
Journal:  Mol Endocrinol       Date:  2000-03

3.  Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling.

Authors:  C Brisken; A Heineman; T Chavarria; B Elenbaas; J Tan; S K Dey; J A McMahon; A P McMahon; R A Weinberg
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

4.  Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland.

Authors:  J Russo; X Ao; C Grill; I H Russo
Journal:  Breast Cancer Res Treat       Date:  1999-02       Impact factor: 4.872

5.  Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.

Authors:  M I Gallego; N Binart; G W Robinson; R Okagaki; K T Coschigano; J Perry; J J Kopchick; T Oka; P A Kelly; L Hennighausen
Journal:  Dev Biol       Date:  2001-01-01       Impact factor: 3.582

6.  Oestrogen receptor alpha in female fetal, infant, and child mammary tissue.

Authors:  J W Keeling; E Ozer; G King; F Walker
Journal:  J Pathol       Date:  2000-08       Impact factor: 7.996

7.  Stem cell repopulation efficiency but not pool size is governed by p27(kip1).

Authors:  T Cheng; N Rodrigues; D Dombkowski; S Stier; D T Scadden
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

8.  Oestrogen receptor expression in the normal and pre-cancerous breast.

Authors:  B S Shoker; C Jarvis; D R Sibson; C Walker; J P Sloane
Journal:  J Pathol       Date:  1999-07       Impact factor: 7.996

9.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

10.  Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development.

Authors:  N C Luetteke; T H Qiu; S E Fenton; K L Troyer; R F Riedel; A Chang; D C Lee
Journal:  Development       Date:  1999-06       Impact factor: 6.868

View more
  38 in total

1.  TGF-β Stimulation of EMT Programs Elicits Non-genomic ER-α Activity and Anti-estrogen Resistance in Breast Cancer Cells.

Authors:  Maozhen Tian; William P Schiemann
Journal:  J Cancer Metastasis Treat       Date:  2017-08-21

2.  The functional effects and mechanisms by which fibroblast growth factor 2 (FGF2) controls bovine mammary epithelial cells: Implications for the development and functionality of the bovine mammary gland.

Authors:  W Jeong; H Bae; W Lim; F W Bazer; H Lee; G Song
Journal:  J Anim Sci       Date:  2017-12       Impact factor: 3.159

3.  Lgr6 labels a rare population of mammary gland progenitor cells that are able to originate luminal mammary tumours.

Authors:  Leander Blaas; Fabio Pucci; Hendrik A Messal; Agneta B Andersson; E Josue Ruiz; Marco Gerling; Iyadh Douagi; Bradley Spencer-Dene; Alexandra Musch; Richard Mitter; Leena Bhaw; Richard Stone; Dorothee Bornhorst; Abdul K Sesay; Jos Jonkers; Gordon Stamp; Ilaria Malanchi; Rune Toftgård; Axel Behrens
Journal:  Nat Cell Biol       Date:  2016-10-31       Impact factor: 28.824

Review 4.  Epithelial-Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance.

Authors:  Alex J Gooding; William P Schiemann
Journal:  Mol Cancer Res       Date:  2020-06-05       Impact factor: 5.852

5.  Lavender Products Associated With Premature Thelarche and Prepubertal Gynecomastia: Case Reports and Endocrine-Disrupting Chemical Activities.

Authors:  J Tyler Ramsey; Yin Li; Yukitomo Arao; Ajanta Naidu; Laurel A Coons; Alejandro Diaz; Kenneth S Korach
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

6.  The IncRNA BORG: A novel inducer of TNBC metastasis, chemoresistance, and disease recurrence.

Authors:  Alex J Gooding; Kimberly A Parker; Saba Valadkhan; William P Schiemann
Journal:  J Cancer Metastasis Treat       Date:  2019-05-10

7.  Glycomics: Immunoglobulin G N-Glycosylation Associated with Mammary Gland Hyperplasia in Women.

Authors:  Zixiu Meng; Cancan Li; Guoyong Ding; Weijie Cao; Xizhu Xu; Yuanyuan Heng; Yang Deng; Yuejin Li; Xiaoyu Zhang; Dong Li; Wei Wang; Youxin Wang; Weijia Xing; Haifeng Hou
Journal:  OMICS       Date:  2020-08-24

Review 8.  Application of the D492 Cell Lines to Explore Breast Morphogenesis, EMT and Cancer Progression in 3D Culture.

Authors:  Eirikur Briem; Saevar Ingthorsson; Gunnhildur Asta Traustadottir; Bylgja Hilmarsdottir; Thorarinn Gudjonsson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-01-25       Impact factor: 2.673

9.  Effects of Pubertal Exposure to Dietary Soy on Estrogen Receptor Activity in the Breast of Cynomolgus Macaques.

Authors:  Fitriya N Dewi; Charles E Wood; Cynthia J Willson; Thomas C Register; Cynthia J Lees; Timothy D Howard; Zhiqing Huang; Susan K Murphy; Janet A Tooze; Jeff W Chou; Lance D Miller; J Mark Cline
Journal:  Cancer Prev Res (Phila)       Date:  2016-03-22

10.  Phosphorylated Progesterone Receptor Isoforms Mediate Opposing Stem Cell and Proliferative Breast Cancer Cell Fates.

Authors:  Thu H Truong; Amy R Dwyer; Caroline H Diep; Hsiangyu Hu; Kyla M Hagen; Carol A Lange
Journal:  Endocrinology       Date:  2019-02-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.